116 related articles for article (PubMed ID: 3524928)
21. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
22. Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients.
Vlahakos DV; Balodimos C; Papachristopoulos V; Vassilakos P; Hinari E; Vlachojannis JG
Clin Nephrol; 1995 Jan; 43(1):53-9. PubMed ID: 7697936
[TBL] [Abstract][Full Text] [Related]
23. Anti-renin-angiotensin-system drugs and development of anemia in chronic kidney disease.
Piccoli A; Pastori G; Pierobon E; Torraca S; Andreucci M; Sabbatini M; Cianciaruso B
J Nephrol; 2005; 18(5):585-91. PubMed ID: 16299686
[TBL] [Abstract][Full Text] [Related]
24. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
25. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
26. Activation of renin-angiotensin system does not cause skeletal muscle cramps during hemodialysis.
Piergies AA; Atkinson AJ; Hubler GL; del Greco F
Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):405-9. PubMed ID: 2258248
[TBL] [Abstract][Full Text] [Related]
27. [The activities of the renin-angiotensin-aldosterone and sympathetic-adrenal systems during hemodialysis].
Akopian AS; Koriakin MV; Golubov AA; Shevchenko AV
Urol Nefrol (Mosk); 1991; (4):45-50. PubMed ID: 1659015
[TBL] [Abstract][Full Text] [Related]
28. [Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension].
Miyazaki N; Shionoiri H; Uneda S; Yasuda G; Gotoh E; Fujishima S; Kaneko Y; Kawahara Y; Yamazaki Y
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):421-8. PubMed ID: 6750186
[No Abstract] [Full Text] [Related]
29. Worsening of anemia induced by long-term use of captopril in hemodialysis patients.
Hirakata H; Onoyama K; Iseki K; Kumagai H; Fujimi S; Omae T
Am J Nephrol; 1984; 4(6):355-60. PubMed ID: 6393769
[TBL] [Abstract][Full Text] [Related]
30. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.
Cole J; Ertoy D; Lin H; Sutliff RL; Ezan E; Guyene TT; Capecchi M; Corvol P; Bernstein KE
J Clin Invest; 2000 Dec; 106(11):1391-8. PubMed ID: 11104792
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis.
Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Nakamura S; Ikeda M; Oikawa T; Fujinami T; Kawahara H
Nephron; 1991; 59(2):334-5. PubMed ID: 1956504
[No Abstract] [Full Text] [Related]
32. Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes.
Marathias KP; Lambadiari VA; Markakis KP; Vlahakos VD; Bacharaki D; Raptis AE; Dimitriadis GD; Vlahakos DV
Am J Nephrol; 2020; 51(5):349-356. PubMed ID: 32241009
[TBL] [Abstract][Full Text] [Related]
33. Anemia and angiotensin-converting enzyme inhibition in renal transplant recipients.
Sizeland PC; Bailey RR; Lynn KL; Robson RA
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S117-9. PubMed ID: 1708009
[TBL] [Abstract][Full Text] [Related]
34. The role of the renin-angiotensin system in the regulation of erythropoiesis.
Vlahakos DV; Marathias KP; Madias NE
Am J Kidney Dis; 2010 Sep; 56(3):558-65. PubMed ID: 20400218
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of the acute antihypertensive effect of captopril in patients on hemodialysis].
Ishimitsu T; Yamakado M; Tagawa H
Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):447-54. PubMed ID: 3528597
[No Abstract] [Full Text] [Related]
36. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 2) change of renin-angiotensin-aldosterone system during hemodialysis (author's transl)].
Fukuchi S; Nakajima K
Nihon Jinzo Gakkai Shi; 1977 Oct; 19(10):809-14. PubMed ID: 604580
[No Abstract] [Full Text] [Related]
37. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease.
Schiffl H; Lang SM
Nephron; 1999 Jan; 81(1):106-8. PubMed ID: 9884431
[No Abstract] [Full Text] [Related]
39. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure.
Wallner SF; Vautrin RM
J Lab Clin Med; 1981 Feb; 97(2):170-8. PubMed ID: 7452088
[TBL] [Abstract][Full Text] [Related]
40. Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure.
Nonoguchi H; Kiyama S; Kitamura K; Naruse M; Tomita M; Tazoe N; Tajiri M; Nakayama Y; Kohda Y; Inoue T; Tomita K
Hypertens Res; 2008 Jan; 31(1):29-36. PubMed ID: 18360015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
